Sienna Biopharmaceuticals (SNNAQ) Stock Price, News & Analysis

Company Overview

Sienna Biopharmaceuticals, Inc. (OTCMKTS: SNNAQ) is a development-stage biopharmaceutical company focused on specialty dermatology. The company seeks to identify, acquire and advance novel therapies designed to treat inflammatory and immune-mediated skin disorders with significant unmet medical need. Through strategic in-licensing and acquisitions, Sienna is building a pipeline of product candidates intended to address conditions such as atopic dermatitis, vitiligo and other chronic dermatologic diseases.

Operating primarily within the United States, Sienna Biopharmaceuticals collaborates with academic research centers and industry partners to conduct preclinical research and clinical trials. Its scientific team applies expertise in drug formulation and targeted delivery to optimize the safety and efficacy profiles of its candidates, positioning them for potential regulatory submissions and commercialization.

Headquartered in Carlsbad, California, Sienna Biopharmaceuticals is guided by a management team with extensive experience in dermatology drug development and commercialization. As a publicly traded company on the OTC Markets, Sienna remains committed to advancing its pipeline toward regulatory milestones and ultimately delivering innovative treatment options for patients suffering from challenging skin conditions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SNNAQ Stock Analysis - Frequently Asked Questions

How do I buy shares of Sienna Biopharmaceuticals?

Shares of SNNAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:SNNAQ
• CIK: 1656328
• Web: www.siennabio.com
• Phone: (818) 629-2256
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.31